Literature DB >> 2008917

Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy.

B A Julian1, V R Cannon, F B Waldo, J Egido.   

Abstract

Although the clinical onset of IgA nephropathy is frequently impossible to define, macroscopic hematuria apparently heralds the onset of the disease in some patients. We describe the clinical course and renal histologic findings of four adults with IgA nephropathy who were diagnosed by the characteristic immunohistologic features in a second renal biopsy specimen. IgA was not detected in the initial renal biopsy specimens obtained 9 months to 4 years earlier. The first renal biopsy had been performed to evaluate macroscopic hematuria (recurrent in three patients), accompanied by pathologic proteinuria in two patients. Our observations suggest that the pathognomonic immunohistologic findings of IgA nephropathy may follow the clinical onset and raise questions about the presumed pathogenetic role of IgA in the early stages of this disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008917     DOI: 10.1016/s0272-6386(12)80643-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study.

Authors:  C Izzi; S Sanna-Cherchi; E Prati; R Belleri; A Remedio; R Tardanico; M Foramitti; S Guerini; B F Viola; E Movilli; I Beerman; R Lifton; L Leone; A Gharavi; F Scolari
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

2.  C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?

Authors:  Mordi Muorah; Manish D Sinha; Catherine Horsfield; Patrick J O'Donnell
Journal:  NDT Plus       Date:  2009-05-09

3.  The kinetics of glomerular deposition of nephritogenic IgA.

Authors:  Kenji Yamaji; Yusuke Suzuki; Hitoshi Suzuki; Kenji Satake; Satoshi Horikoshi; Jan Novak; Yasuhiko Tomino
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.